PCR Duplication: A One-Step Cloning-Free Method to Generate Duplicated Chromosomal Loci and Interference-Free Expression Reporters in Yeast

PLoS One. 2014 Dec 10;9(12):e114590. doi: 10.1371/journal.pone.0114590. eCollection 2014.

Abstract

Here, we report on a novel PCR targeting-based strategy called 'PCR duplication' that enables targeted duplications of genomic regions in the yeast genome using a simple PCR-based approach. To demonstrate its application we first duplicated the promoter of the FAR1 gene in yeast and simultaneously inserted a GFP downstream of it. This created a reporter for promoter activity while leaving the FAR1 gene fully intact. In another experiment, we used PCR duplication to increase the dosage of a gene in a discrete manner, from 1× to 2x. Using TUB4, the gene encoding for the yeast γ-tubulin, we validated that this led to corresponding increases in the levels of mRNA and protein. PCR duplication is an easy one-step procedure that can be adapted in different ways to permit rapid, disturbance-free investigation of various genomic regulatory elements without the need for ex vivo cloning.

MeSH terms

  • Cyclin-Dependent Kinase Inhibitor Proteins / genetics*
  • Gene Duplication / genetics*
  • Genes, Reporter / genetics
  • Polymerase Chain Reaction / methods*
  • Promoter Regions, Genetic / genetics
  • RNA, Messenger / genetics
  • Regulatory Elements, Transcriptional / genetics
  • Saccharomyces cerevisiae / genetics*
  • Saccharomyces cerevisiae Proteins / genetics*
  • Tubulin / genetics*

Substances

  • Cyclin-Dependent Kinase Inhibitor Proteins
  • FAR1 protein, S cerevisiae
  • RNA, Messenger
  • Saccharomyces cerevisiae Proteins
  • TUB4 protein, S cerevisiae
  • Tubulin

Associated data

  • Dryad/10.5061/dryad.gj51n

Grants and funding

FH was supported by the SFB1036 of the DFG (Deutsche Forschungsgemeinschaft, www.dfg.de/en), MM and MS by the CellNetworks Cluster of Excellence (www.cellnetworks.uni-hd.de), MS in addition by the Alexander von Humboldt Foundation (www.humboldt-foundation.de/web/home.html), IK by the HBIGS graduate school (Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, www.hbigs.uni-heidelberg.de) and DB received funding from the Boehringer Ingelheim Stiftung für medizinische Grundlagenforschung (www.bifonds.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.